SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin

BACKGROUND: Randomized clinical trials (RCTs) of interventions for the hepatitis C virus have historically used sustained virological response (SVR) at 24 weeks after treatment (SVR24) as the key effect measure. However, recent RCTs investigating the efficacy of new direct acting agents (DAAs) have...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Thorlund, Kristian, Druyts, Eric, Mills, Edward J
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2014
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3897323/
https://ncbi.nlm.nih.gov/pubmed/24474846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S53302
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky